HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Symrise Develops Testing Alternative From Piggies Going To Meat Market

This article was originally published in The Rose Sheet

Executive Summary

Symrise's ex-vivo pig-skin-based animal testing alternative under development could benefit "the entire international cosmetic industry," the flavors and fragrances developer says

You may also be interested in...

EU animal testing

Council of Ministers adopts Seventh Amendment to the Cosmetics Directive banning animal testing on cosmetics. Legislation, passed during the Council's Jan. 27-28 meeting, is in line with joint text agreed upon in conciliation with European Parliament, which passed the amendment Jan. 15. Long-debated marketing/testing ban passed conciliation in November prohibiting testing of cosmetics on animals immediately when alternative methods are available and imposing a six-year deadline for most tests when validated alternatives are not yet available (1"The Rose Sheet" Nov. 25, 2002, p. 6)...

No To Grapefruit Mask? Natural Player Yes To, Inc. Issues Recall Following ‘Chemical Burn’ Reports

Yes To is investigating reports – including posts on leading social media platforms – regarding irritation and redness experienced by children and other users of its Yes To Grapefruit Glow-Boosting Unicorn Paper Mask. In the meantime, the company is recalling the product voluntarily.

Federal Court Stays Class Action Against CBD Firm Green Roads To Await FDA Rulemaking

Plaintiffs against Florida-based Green Roads used certificates of analysis the company makes freely available to consumers to determine that batches of two of the company’s products contained “significantly” less cannabidiol versus labeled amounts. A Florida federal court rejected the firm’s motion to dismiss, but it is interested in seeing how FDA rulemaking develops.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts